Tonix Pharmaceuticals TNX-102 SL Pharmacokinetic Properties 2024

Loading viewer...

conference

Format: PDF conference

Tonix Pharmaceuticals presents pharmacokinetic data on TNX-102 SL, a novel sublingual formulation of cyclobenzaprine hydrochloride, at the 2024 Pharmaceutics and Novel Drug Delivery Systems Conference. The oral presentation by Bruce Daugherty, PhD, details the formulation development and bioavailability characteristics of this investigational drug candidate.

Browse all conferences →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Tonix Pharmaceuticals Holding Corp.

View all →

Tonix Pharmaceuticals BIO 2024 Corporate Presentation

conference

23 Pages

Tonix Pharmaceuticals Corporate Presentation February 2017

investor_presentation

Similar conferences from other companies

Browse all →

SM Energy 2016 Capital One Securities Energy Conference Presentation

conference

44 Pages

SM Energy

Emdeon 2017 J.P. Morgan Healthcare Conference Presentation

conference